(Q51563657)

English

Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens.

scientific article published on 27 May 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/21623384

Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens. (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/21623384

1 reference

based on heuristic

inferred from title

immunohistochemistry

1 reference

based on heuristic

inferred from title

squamous cell carcinoma

1 reference

based on heuristic

inferred from title

3

object named as

Camelia S Sima

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/21623384

author name string

Natasha Rekhtman

1

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/21623384

Daphne C Ang

2

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/21623384

William D Travis

4

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/21623384

Andre L Moreira

5

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/21623384

publication date

27 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/21623384

Modern Pathology

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/21623384

24

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/21623384

10

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/21623384

1348-1359

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/21623384

Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Preoperative histological classification of primary lung cancer: accuracy of diagnosis and use of the non-small cell category

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Carcinoma NOS is a common histologic diagnosis and is increasing in proportion among non-small cell lung cancer histologies

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

A reevaluation of the clinical significance of histological subtyping of non--small-cell lung carcinoma: diagnostic algorithms in the era of personalized treatments

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Suitability of thoracic cytology for new therapeutic paradigms in non-small cell lung carcinoma: high accuracy of tumor subtyping and feasibility of EGFR and KRAS molecular testing

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

P63 in pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

P63 expression in lung carcinoma: a tissue microarray study of 408 cases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

A novel five-antibody immunohistochemical test for subclassification of lung carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

The use of P63 immunohistochemistry for the identification of squamous cell carcinoma of the lung.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Pathological diagnosis and classification of lung cancer in small biopsies and cytology: strategic management of tissue for molecular testing

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

TTF-1 expression in pulmonary adenocarcinomas.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Comparison of thyroid transcription factor-1 expression by 2 monoclonal antibodies in pulmonary and nonpulmonary primary tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Progenitor stem cell marker expression by pulmonary carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

TTF-1 expression in ovarian and uterine epithelial neoplasia and its potential significance, an immunohistochemical assessment with multiple monoclonal antibodies and different secondary detection systems.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Thyroid transcription factor-1 expression in breast carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Differences in clinicopathological and biological features between central-type and peripheral-type squamous cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Desmocollin-3: a new marker of squamous differentiation in undifferentiated large-cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Selective expression of S100A7 in lung squamous cell carcinomas and large cell carcinomas but not in adenocarcinomas and small cell carcinomas.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

miR-205 Expression levels in nonsmall cell lung cancer do not always distinguish adenocarcinomas from squamous cell carcinomas.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

AIS is an oncogene amplified in squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

The fine structure of large cell undifferentiated carcinoma of the lung. Evidence for its relation to squamous cell carcinomas and adenocarcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Large cell carcinoma of the lung: an endangered species?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Frequent ALK rearrangement and TTF-1/p63 co-expression in lung adenocarcinoma with signet-ring cell component.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Treatment-by-Histology Interaction Analyses in Three Phase III Trials Show Superiority of Pemetrexed in Nonsquamous Non-small Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathologic Diagnosis of Advanced Lung Cancer Based on Small Biopsies and Cytology: A Paradigm Shift

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Morphology and a limited number of immunohistochemical markers may efficiently subtype non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemical subtyping of nonsmall cell lung cancer not otherwise specified in fine-needle aspiration cytology: a retrospective study of 103 cases with surgical correlation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of p63, keratin 5/6, keratin 7, and surfactant-A in non-small cell lung carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid multiplex immunohistochemistry using the 4-antibody cocktail YANA-4 in differentiating primary adenocarcinoma from squamous cell carcinoma of the lung.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

7 January 2021

based on heuristic

inferred from DOI database lookup

TTF-1, cytokeratin 7, 34betaE12, and CD56/NCAM immunostaining in the subclassification of large cell carcinomas of the lung

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/MODPATHOL.2011.92

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/21623384

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/21623384

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51563657&oldid=2210903515"